Rocket Pharmaceuticals Announces Participation at Upcoming Investor Conferences

On August 30, 2018 Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) ("Rocket"), a leading U.S.-based multi-platform gene therapy company, reported that members of Rocket’s executive team will participate in the following upcoming investor conferences (Press release, Rocket Pharmaceuticals, AUG 30, 2018, View Source [SID1234529197]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s 13th Annual Biotech Conference on September 6, 2018 in Boston, MA
Morgan Stanley 16th Annual Global Healthcare Conference on September 13, 2018 at 5:15 p.m. Eastern Time in New York, NY

A live audio webcast of the Morgan Stanley fireside chat will be available on the Investors section of the company’s website, www.rocketpharma.com. A replay of the presentation will be archived on the Rocket website following the conference.